Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
CYTOGENETICS AND LONG-TERM SURVIVAL IN MM-003, A PHASE 3 TRIAL OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA
Meletios A Dimopoulos, Katja Weisel, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, A. Baños, Albert Oriol, Laurent Garderet, Michèle Cavo, Иванова , Adrían Alegre, Joaquín Martínez‐López, C. I Chen, A. Spencer, Stefan Knop, NJ Bahlis, C. Renner, Xiaoyan Yu, Kelvin Hong, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Jesús F. San Miguel (2014). CYTOGENETICS AND LONG-TERM SURVIVAL IN MM-003, A PHASE 3 TRIAL OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA. , 99
Article36 days agoMM-003, A PHASE 3 STUDY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA: OUTCOMES BY PRIOR THERAPY AND RESPONSE DEPTH
Jesús F. San Miguel, Katja Weisel, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, A. Baños, Albert Oriol, Laurent Garderet, Michèle Cavo, Иванова , Adrían Alegre, Joaquín Martínez‐López, C. I Chen, C. Renner, NJ Bahlis, Xiaoyan Yu, T Teasdale, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Meletios A Dimopoulos (2014). MM-003, A PHASE 3 STUDY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA: OUTCOMES BY PRIOR THERAPY AND RESPONSE DEPTH. , 99
Article36 days agoPHASE 3 STUDY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: MM-003 SUBANALYSIS OF ELDERLY PATIENTS (> 65 AND > 70 YEARS OF AGE)
Katja Weisel, Jesús F. San Miguel, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, A. Baños, Albert Oriol, Laurent Garderet, Michèle Cavo, Иванова , Adrían Alegre, Joaquín Martínez‐López, C. I Chen, Stefan Knop, Xiaoyan Yu, Latisha Watkins, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Meletios A Dimopoulos (2014). PHASE 3 STUDY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: MM-003 SUBANALYSIS OF ELDERLY PATIENTS (> 65 AND > 70 YEARS OF AGE). , 99
Article36 days agoPomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
Jesús F. San Miguel, Katja Weisel, Philippe Moreau, Martha Q. Lacy, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Anne Banos, Albert Oriol, Adrían Alegre, Christine Chen, Michèle Cavo, Laurent Garderet, Valentina Ivanova, Joaquín Martínez‐López, Andrew R. Belch, Antonio Palumbo, Stephen Schey, Pieter Sonneveld, Xin Yu, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Meletios A Dimopoulos (2013). Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial. , 14(11), DOI: https://doi.org/10.1016/s1470-2045(13)70380-2.
Article36 days agoFinal Analysis, Cytogenetics, Long-Term Treatment, and Long-Term Survival In MM-003, A Phase 3 Study Comparing Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM)
Meletios A Dimopoulos, Katja Weisel, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, Anne Banos, Albert Oriol, Laurent Garderet, Michèle Cavo, Valentina Ivanova, Adrían Alegre, Joaquín Martínez‐López, Christine I. Chen, Andrew Spencer, Stefan Knop, Nizar J. Bahlis, Christoph Renner, Xin Yu, Kevin Hong, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Jesús F. San Miguel (2013). Final Analysis, Cytogenetics, Long-Term Treatment, and Long-Term Survival In MM-003, A Phase 3 Study Comparing Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM). , 122(21), DOI: https://doi.org/10.1182/blood.v122.21.408.408.
Article36 days ago